HRTX R&D to Revenue
Heron Therapeutics Inc · R&D to Revenue
HRTX R&D to Revenue
Latest reported8.02%period ending
HRTX FY R&D/Revenue (0.00% → 8.02%)
Latest values, visible window
High-resolution chart · PNG
HRTX r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 8.0237% | |
| 11.5625% | |
| 30.8027% | |
| 76.8111% | |
| 151.5079% | |
| 196.9054% | |
| 114.6703% | |
| 180.7471% | |
| 450.4242% | |
| 8,062.9398% | |
| 0% | |
| 0% | |
| 0% | |
| 2,328.9474% | |
| 1,270.4334% | |
| 558.3397% | |
| 618.2395% | |
| 5,286.4499% | |
| 4,700% | |
| 282.6192% | |
| 191.0406% | |
| 212.7128% | |
| 178.6304% | |
| 115.2021% | |
| 167.4949% | |
| 110.309% | |
| 21.0784% | |
| 22% | |
| 21.5116% | |
| 18.7166% | |
| 25.4658% | |
| 39.6226% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |